Shanghai Haohai Biological Technology Co (HKSE:06826) Change In Receivables : HK$0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Shanghai Haohai Biological Technology Co Change In Receivables?

Shanghai Haohai Biological Technology Co's change in receivables for the quarter that ended in Dec. 2024 was HK$0 Mil. It means Shanghai Haohai Biological Technology Co's Accounts Receivable stayed the same from Sep. 2024 to Dec. 2024 .

Shanghai Haohai Biological Technology Co's change in receivables for the fiscal year that ended in Dec. 2024 was HK$-42 Mil. It means Shanghai Haohai Biological Technology Co's Accounts Receivable increased by HK$42 Mil from Dec. 2023 to Dec. 2024 .

Shanghai Haohai Biological Technology Co's Accounts Receivable for the quarter that ended in Dec. 2024 was HK$338 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shanghai Haohai Biological Technology Co's Days Sales Outstanding for the three months ended in Dec. 2024 was 47.69.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shanghai Haohai Biological Technology Co's liquidation value for the three months ended in Dec. 2024 was HK$2,130 Mil.

Shanghai Haohai Biological Technology Co Change In Receivables Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co Change In Receivables Chart

Shanghai Haohai Biological Technology Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

18.54

-51.33

-58.44

11.08

-42.01

Shanghai Haohai Biological Technology Co Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Shanghai Haohai Biological Technology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.

Shanghai Haohai Biological Technology Co (HKSE:06826) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shanghai Haohai Biological Technology Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	337.502	/	645.788	*	91
=	47.69

2. In Ben Graham's calculation of liquidation value, Shanghai Haohai Biological Technology Co's accounts receivable are only considered to be worth 75% of book value:

Shanghai Haohai Biological Technology Co's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2901.027	-	1285.852	+	0.75 * 337.502	+	0.5 * 523.854
=	2,130

Shanghai Haohai Biological Technology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Haohai Biological Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

688366:China

Address

No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN

Website

https://www.3healthcare.com

Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.

Executives

Morgan Stanley	2201 Interest of corporation controlled by you
Dalton Investments Llc	2102 Investment manager
The Bank Of New York Mellon Corporation	2201 Interest of corporation controlled by you
Templeton Investment Counsel, Llc	2102 Investment manager
Kabouter Management Llc	2102 Investment manager
Royal Bank Of Canada	2201 Interest of corporation controlled by you
Kabouter International Insight Fund, Llc	2102 Investment manager
Prudence Investment Management (hong Kong) Limited	2102 Investment manager

Shanghai Haohai Biological Technology Co Headlines

No Headlines